X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (26) 26
humans (22) 22
hematology (13) 13
article (10) 10
leukemia (10) 10
female (9) 9
middle aged (9) 9
adult (8) 8
aged (8) 8
animals (8) 8
male (8) 8
oncology (8) 8
hemic and lymphatic diseases (7) 7
protein kinase inhibitors - pharmacology (7) 7
stem cells (7) 7
cell line, tumor (6) 6
drug resistance (6) 6
mast cells - metabolism (6) 6
mice (6) 6
activating mutation (5) 5
aged, 80 and over (5) 5
c-kit (5) 5
chronic myelogenous leukemia (5) 5
chronic myeloid-leukemia (5) 5
cml (5) 5
imatinib (5) 5
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (5) 5
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (5) 5
leukemia, myelogenous, chronic, bcr-abl positive - pathology (5) 5
mastocytosis, systemic - metabolism (5) 5
neoplastic stem cells - metabolism (5) 5
of-the-art (5) 5
protooncogene c-kit (5) 5
response criteria (5) 5
stem-cells (5) 5
acute myeloid-leukemia (4) 4
apoptosis - drug effects (4) 4
cell biology (4) 4
cell proliferation - drug effects (4) 4
diagnostic-criteria (4) 4
drug synergism (4) 4
kit (4) 4
mast cell leukemia (4) 4
mast cells (4) 4
mast cells - drug effects (4) 4
mast cells - pathology (4) 4
mastocytosis (4) 4
research (4) 4
stat5 transcription factor - metabolism (4) 4
systemic mastocytosis (4) 4
tyrosine kinase inhibitors (4) 4
abridged index medicus (3) 3
activation (3) 3
advanced systemic mastocytosis (3) 3
bcr-abl (3) 3
cancer (3) 3
chronic myeloid leukemia (3) 3
dermatology (3) 3
expression (3) 3
flow cytometry (3) 3
imatinib mesylate (3) 3
initiating cells (3) 3
kinases (3) 3
mastocytosis, systemic - pathology (3) 3
medical colleges (3) 3
mice, inbred nod (3) 3
mice, scid (3) 3
mutation (3) 3
neoplastic stem cells - pathology (3) 3
patient outcomes (3) 3
resistance (3) 3
therapy (3) 3
tyrosine (3) 3
adp-ribosyl cyclase 1 - metabolism (2) 2
analysis (2) 2
antigens, cd34 - metabolism (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic agents - therapeutic use (2) 2
apoptosis (2) 2
bcr-abl1 t315i (2) 2
biochemistry (2) 2
biomarkers, tumor - metabolism (2) 2
bone marrow - pathology (2) 2
bosutinib (2) 2
cancer stem cells (2) 2
care and treatment (2) 2
catalytic domain (2) 2
cd25 (2) 2
cd25 antigen (2) 2
cd26 (2) 2
cd26 antigen (2) 2
cd34 antigen (2) 2
cd38 antigen (2) 2
cell differentiation - physiology (2) 2
cell movement (2) 2
cells, cultured (2) 2
chromosome-positive leukemias (2) 2
classification (2) 2
cluster formation (2) 2
dasatinib bms-354825 (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Leukemia, ISSN 0887-6924, 04/2019, Volume 33, Issue 11, pp. 2673 - 2684
Mast cell leukemia (MCL) is a highly fatal malignancy characterized by devastating expansion of immature mast cells in various organs. Although considered a... 
Drugs | CD34 antigen | Antigens | Chronic lymphatic leukemia | CD26 antigen | Purification | Leukemia | Organs | Stem cell transplantation | CD13 antigen | Drug delivery | Malignancy | Interleukin 1 receptors | Cell surface | Depletion | CD38 antigen | Stem cells | CD25 antigen | Mast cells | Mast cell leukemia
Journal Article
Neoplasia, ISSN 1476-5586, 06/2018, Volume 20, Issue 6, pp. 632 - 642
Journal Article
Journal of Leukocyte Biology, ISSN 0741-5400, 01/2014, Volume 95, Issue 1, pp. 95 - 104
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1363 - 1363
Abstract Aggressive systemic mastocytosis (ASM) and mast cell leukemia (MCL) are rare, malignant diseases with an unfavorable prognosis. In a majority of... 
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 139, Issue 6, pp. 1873 - 1884.e10
Background Langerhans cell (LC) networks play key roles in immunity and tolerance at body surfaces. LCs are established prenatally and can be replenished from... 
Allergy and Immunology | lineage decision | Runt-related transcription factor 3 | TGF-β1 signaling | monocyte differentiation | Kruppel-like factor 4 | Notch | TGF-BETA | COLONY-STIMULATING FACTOR | CORD BLOOD | IMMUNOLOGY | CLUSTER FORMATION | HEMATOPOIETIC PROGENITORS | EPIDERMAL LANGERHANS CELLS | IN-VITRO | ALLERGY | PERIPHERAL-BLOOD MONOCYTES | NOTCH LIGAND | T-CELLS | TGF-beta 1 signaling | Skin - cytology | Embryo, Mammalian | Monocytes - cytology | Humans | Cells, Cultured | Monocytes - metabolism | Fetal Blood - cytology | Inflammation - metabolism | Kruppel-Like Transcription Factors - metabolism | Adult | Dendritic Cells - cytology | Cell Differentiation - physiology | Dendritic Cells - metabolism | Transforming Growth Factor beta1 - pharmacology | Medical colleges | Inflammation | Skin | Dendritic cells | Networks | Correlation | Transcription factors | Profiling | Genes | Differentiation (biology) | Surface chemistry | Activation | Kinases | Macrophages | Dermatitis | Immunity | Blood | Inflammatory diseases | Cell adhesion & migration | Signal transduction | Cell activation | KLF4 protein | Cell fate | Lymphocytes | Eczema | Skin diseases | Mathematical models | Inhibition | Lesions | Kruppel protein | Immunoglobulins | Cytokines | Markers | Gene expression | Cell differentiation | Steady state | Immunological tolerance | Diseases | Monocytes | Ligands | Notch protein
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4223 - 4223
Chronic myelomonocytic leukemia (CMML) is a stem cell-derived hematopoietic neoplasm characterized by dysplasia, uncontrolled expansion of monocytic... 
Journal Article
Experimental Hematology, ISSN 0301-472X, 07/2017, Volume 51, p. 17
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.exphem.2017.04.003 
Medical colleges | Diagnosis | Interleukins | Leukemia | Stem cells
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1722 - 1722
Abstract Chronic myeloid leukemia (CML) is a hematopoietic stem cell neoplasm in which BCR-ABL1 acts as a major driver of proliferation, differentiation and... 
Journal Article
Experimental Hematology, ISSN 0301-472X, 01/2018, Volume 57, p. 50
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.exphem.2017.09.012 
Antimitotic agents | Myelocytic leukemia | Analysis | Stem cells | Nonlymphoid leukemia | Drug therapy, Combination | Antineoplastic agents
Journal Article
Haematologica, ISSN 0390-6078, 04/2019, p. haematol.2019.217950
A high allele burden of the KIT D816V mutation in peripheral blood or bone marrow aspirates indicates multi-lineage hematopoietic involvement and has been... 
Journal Article
Leukemia, ISSN 0887-6924, 11/2017, Volume 31, Issue 11, pp. 2388 - 2397
Journal Article
Journal Article
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, ISSN 1422-0067, 09/2019, Volume 20, Issue 17, p. 4233
Journal Article